Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for lactate clearance in ICU patients with sepsis
IRCT20180410039254N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in sepsis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Effect of magnesium supplementation on lactate clearance, Correlation between serum magnesium level and lactate clearance and 1 more. Started Jun 2018; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT20180410039254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180410039254N1.